Penny Stock in Focus: Cannabis Science Inc. (CBIS) to begin IND application with FDA
Thursday, January 26th, 2012 | Filed under Breaking News,Internet | Posted by Terrel Sugar
Shares of Cannabis Science Inc. (OTC: CBIS), a medical marijuana company, climbed in Wednesday’s trading session. The penny stock of Cannabis Science ended the day 3.57% higher at $0.0435, with volume up from daily average of 16.03 million to 32.26 million.
Cannabis Science on Wednesday announced that the current progress and success with its numerous self-medicated cancer patients has led it to the immediate start of the Investigational New Drug (IND) application process that will target cancer treatment.
Cannabis Science said that it is currently tracking a number of cancer patients, who are self-medicating with cannabis extracts. The company said that there is evidence of success with a number of these patients, which lends support to an IND application to the FDA.
The company believes that it is an excellent position to start the FDA process for prescription cancer medications.